Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
861998-00-7CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1.ClVFYAEUWJFGTGGO-GHTUPXNNSA-N861998-00-7DTXSID70235443CHEMBL2103794BeschreibungAnamorelin Monohydrochloride, also known as ONO-7643, RC-1291, and ST-1291, is a drug developed by Novo Nordisk A/S and later licensed by Helsinn Healthcare SA and Ono Pharmaceutical Co. Anamorelin is used for the treatment of cancer anorexia and cachexia syndrome (CACS), a cancer-related side effect manifested by loss of appetite, weight loss, muscle wasting, and reduced quality of life.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…